About Cardiac Resynchronization Therapy-pacemaker (CRT-P)
CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals. Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.
Technavio’s analysts forecast the global cardiac resynchronization therapy-pacemaker (CRT-P) market to grow at a CAGR of 8.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy-pacemaker (CRT-P) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of CRT-Ps.The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market:
BIOTRONIK, Boston Scientific, LivaNova, Medtronic, and St. Jude Medical.
Commenting on the report, an analyst from Technavio’s team said: “Popularity of robot-assisted cardiac surgery is a key trend in the market. Robotic technology provides physicians with a better view of the operative field and easy movement of instruments with precision and control within close-fitting spaces. These surgeries help reduce the duration of hospital stays, facilitating better cost management. These procedures also prevent human errors and ensure improved outcomes, reduced recovery periods, and minimal pain and discomfort.”
According to the report, there is an increase in the incidence of cardiovascular diseases. Cardiovascular diseases such as heart attack, coronary artery disease, cardiomyopathy hypertension, heart arrhythmias, and congenital heart defects can cause heart failures. The incidence of these diseases is rising, with sudden cardiac arrest being the leading cause of death worldwide among people aged above 40.
Further, the report states that there is a high risk of potential complications in the implantation of CRT-Ps. Implantation of CRT-Ps at an advanced age is associated with a high probability of mortality. Some other complications related to CRT-Ps include allergic or physiologic reactions, infections, lead erosion or migration, lead breakage, hematoma or seroma, inaccurate or inability to provide pacing, lead tip deformation, component failure, and inappropriate detections due to diaphragmatic myopotential oversensing.
BIOTRONIK, Boston Scientific, LivaNova, Medtronic, St. Jude Medical
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook